Article

Stephen J. Ryan, MD, dies

Stephen J. Ryan, MD, a member of the Allergan Board of Directors, died on April 29, 2013 after a short illness.

 

Irvine, CA-Stephen J. Ryan, MD, died on April 29, 2013 after a short illness. He was 72 years old.

Dr. Ryan was an internationally recognized expert in the field of retinal disease and ocular trauma and a member of the Allergan Board of Directors.

“Steve, in all his modesty, was one of the greatest retinal surgeons and worldwide ophthalmic experts and, in fact, trained many of today’s global leaders in ophthalmology,” said David E.I. Pyott, chairman, president, and chief executive officer, Allergan. “During our many years of working together, I have valued Steve’s perspective and guidance. All of us who have had the privilege of working with Steve will miss him greatly, not only as a colleague, but as a friend.”

Dr. Ryan was recognized as a Laureate of the American Academy of Ophthalmology. He also served as president of the Doheny Eye Institute and as the Distinguished Grace and Emery Beardsley Professor of Ophthalmology at the Keck School of Medicine of the University of Southern California.

Dr. Ryan joined the Allergan Board of Directors in 2002. During his tenure, Dr. Ryan served as Chairman of the Board’s Science and Technology Committee and as a member of the Audit and Finance Committee. In January 2013, he announced his retirement from the Allergan Board of Directors.

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
© 2025 MJH Life Sciences

All rights reserved.